SYNERGY-NASH results were presented at the European Association for the Study of the Liver Congress 2024 and simultaneously published in The New England Journal of Medicine
Thermo Fisher has equipped this Centre for Innovation with state-of-the-art platforms such as CellInsight CX7 LZR Pro High Content Screening Platform
Through our research, we aim to ultimately provide new options for our customers to treat life-threatening infections in livestock
The company received gross proceeds of approximately US$1.7 million and net proceeds,
Lacosamide is indicated to treat partial-onset seizures
OCEANIC-AF is one trial which evaluates asundexian versus apixaban in patients with atrial fibrillation at risk for stroke within the overall OCEANIC phase III program
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
NRT offers 50% higher success rate in quitting smoking compared to unassisted attempts
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Digital success is contingent on the way a company organizes itself around technology
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
